Wednesday, February 03, 2021, 3.02 p.m.
On February 3, 2020, Mr. Anutin Charnvirakul, Minister of Public Health Presided over a meeting of the top executives of the Ministry of Public Health. One of the key issues on today’s agenda is the provision of the COVID-19 vaccine. Which is an urgent mission of the Ministry of Public Health In conjunction with providing fast and safe
Thailand is likely to receive a large number of vaccines by the middle of the year. But in the meantime It contacted several manufacturers to find a way to bring the vaccine faster, until one was available in February. But later on the issue of EU export restrictions, however, did not give up but let the relevant authorities take action to clarify this matter.
In addition, the Department of Disease Control Has assigned the Government Pharmaceutical Organization Rush to buy 2 million vaccines from another collision. And have already been agreed Only the vaccine registration and documentation are left. Which if there is no problem with approval to export from the country of origin The vaccine is expected to be delivered in time by February.
China begins production of AstraZeneca’s COVID vaccine
Xinhua news agency reported that Shenzhen Kang Tai Biological Products Co., Ltd., a pharmaceutical manufacturer in Shenzhen. Guangdong Province, southern China Started trial production of a vaccine against COVID-19. Of AstraZeneca, a British and Swedish company
The report states that The Shenzhen Kangtai Company has built a 2,200 square meter plant with a production capacity of 400 million doses per year to produce the COVID-19 vaccine. Using adinovirus as a carrier Developed by AstraZeneca in collaboration with the University of Oxford. And it was approved for use as an emergency in the UK on 30 Dec 2020.
The Shenzhen company Kang Tai signed an agreement with AstraZeneca in August. 2020 to import vaccines and submit clinical registration.
Meanwhile, the Shenzhen company Kang Tai is still in the process of developing a vaccine against COVID-19. Using a dead infection And is planning to start testing phase 3
Canada prepares to produce COVID-19 vaccine Of their own by the end of 2021.
Canadian Prime Minister Justin Trudeau signs a preliminary agreement with U.S. vaccine company Novavax to produce the COVID-19 vaccine. Millions of doses at the Montreal facility To bring this vaccine for domestic use By in the press release The Canadian Prime Minister stated that It intends to enter into agreements with several companies to produce their own vaccines in the country. Instead of imports that are having problems with the production process It is important for Canada at this time to be self-sufficient in vaccine production.
Nova Wax is currently in clinical trials. But more information was sent to Health Canada about the test last week. And there was an agreement to buy 52 million doses of the vaccine once the Canadian regulator approved the vaccine. It is expected that it will take several weeks for consideration. And domestic vaccine production will take place at the end of the year. This leaves Canada in a short-term shortage of vaccines.
Canada currently approves Pfizer / Biotech and Moderna vaccines, but the two companies have significantly delayed deliveries of the vaccine to Canada due to production delays and pressure on Europe. Have both companies deliver the vaccine first Previously, Mr. Donald Trump, former President of the United States. Export of vaccines from factories in the United States is not yet permitted. Many Canadians are upset that the government has not made efforts to replace the missing number of vaccines.
–
